Financhill
Sell
28

AGIO Quote, Financials, Valuation and Earnings

Last price:
$31.24
Seasonality move :
9.03%
Day range:
$30.64 - $32.20
52-week range:
$27.14 - $62.58
Dividend yield:
0%
P/E ratio:
2.82x
P/S ratio:
50.49x
P/B ratio:
1.19x
Volume:
624.9K
Avg. volume:
700.7K
1-year change:
6.85%
Market cap:
$1.8B
Revenue:
$36.5M
EPS (TTM):
$11.34

AGIO Analysts' Consensus Rating

The 6 analysts providing 12-month price projections for Agios Pharmaceuticals shares anticipate an average target of $54.57, ranging from a low estimate of $43.00 to a high estimate of $74.00. This average target implies a growth of 70.59% compared to the current stock price of $31.99.

Consensus Price Target

$54.57

Highest Price Target

$74.00

Lowest Price Target

$43.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 3 3

Hold 3 3 3

Sell 0 0 0
Consensus Leans Bullish Leans Bullish Leans Bullish

AGIO Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock